Generated by AI
Viatris Inc. is a global healthcare company that develops, manufactures, and markets prescription medicines across a broad range of therapeutic areas. Its portfolio includes branded medicines, generic drugs, complex generics, and biosimilars, serving patients and healthcare providers in developed and emerging markets. The company also supplies active pharmaceutical ingredients used in pharmaceutical manufacturing and supports access to medicines through broad commercial and distribution capabilities. Viatris Inc. operates across regions including North America, Europe, Greater China, Japan, Australia, New Zealand, Latin America, Africa, and the Middle East. Its products address conditions in areas such as cardiovascular health, infectious diseases, central nervous system disorders, immunology, and oncology. By combining established brands with off-patent and technically complex medicines, Viatris Inc. occupies an important role in the global pharmaceutical market, helping manufacturers, healthcare systems, and patients access a wide range of essential treatments.
WebsiteRobert J. Coury Global Center
Canonsburg, PA, 15317
United States
The latest articles about VTRS.
Summary of Oct 30's posts. Generated by AI.
Summary of Jul 17's posts. Generated by AI.
Summary of Feb 26's posts. Generated by AI.
Summary of Oct 8's posts. Generated by AI.
Investors talking about VTRS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.